(R)-5-Bromo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride

Catalog No. :
ACCPKL718
CAS No. :
1638668-15-1
Molecular Formula :
C10H11BrClNO2
Molecular Weight :
292.56

IUPAC Name:(R)-5-bromo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride

(R)-5-Bromo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-5-Bromo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
IUPAC Name(R)-5-bromo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
MDL No.MFCD28502812
Molecular FormulaC10H11BrClNO2
Molecular Weight292.56
SMILESO=C([C@@H]1NCC2=C(C(Br)=CC=C2)C1)O.[H]Cl
InChI KeyQNSTWZBFWXFFJP-SBSPUUFOSA-N
SynonymEOS-62315;(3R)-5-BROMO-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID HCL;(R)-5-BROMO-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID HYDROCHLORIDE;(3R)-5-bromo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid;(3R)-5-bromo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
CAS No.1638668-15-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCPKL718 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCPKL718 route product structure diagram
    ACCPKL7181638668-15-1
Inquiry

2. ACCPKL718 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCPKL718 route product structure diagram
    ACCPKL7181638668-15-1
Inquiry

Comments (0)